Evaluation of the effect of using different doses of levothyroxine on some biochemical parameters in hypothyriod patients
Keywords:
hepcidin hormone, hypothyroidism, levothyroxine, ALT, ALP, ASTAbstract
The current study included the collection of ninety serum samples to evaluate the effect of using different doses of levothyroxine on some biochemical parameters in patients with thyroid disorders. Samples were collected for the period between 15/9/21 to 10/1/2022. Sixty samples were taken from patients with hypothyroidism(G1) who subdivided into two subgroups; 26 of them took the levothyroxine dose of 200 µg/day (G2), and 34 of them took the levothyroxine dose of 100 µg/day (G3), and 30 samples were taken as a control group, their ages ranged between (46-60) years. The level of hepcidin hormone and the activity of the alkaline phosphatase-ALP, Alanine amino transferase-ALT, and Aspartate amino transferase-AST enzymes were evaluated in the serum of hypothyroid patients and healthy subjects as a control group. The results showed that the level of hepcidin hormone significantly (P≤0.05) elevated in serum of patients in group (G3) than the control group and the rest of the other groups. The results showed a significant increase(P≤0.05) in the activity of aspartate aminotransferase enzyme, alanine transferase enzyme and alkaline phosphatase enzyme activities in the serum of patients with hypothyroidism compared to the control group.
Downloads
References
Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017;390(10101):1550-1562.
Udovcic, M., Pena, R. H., Patham, B., Tabatabai, L., & Kansara, A. (2017). Hypothyroidism and the heart. Methodist DeBakey cardiovascular journal, 13(2), 55.
Guyton, A. C. and Hall, J. E. (2016). Textbook of medical physiology. 11th (ed). Elsevier Saunders. China. pp : 404-931-942; 1014-1073.
Truter, I. (2011). Clinical review: Hyper-and hypothyroidism: Evidence-based pharmacy practice. SA Pharmaceutical Journal, 78(6), 10-14.
Shahid, M. A., Ashraf, M. A., & Sharma, S. (2018). Physiology, thyroid hormone.
Su, X., Peng, H., Chen, X., Wu, X., & Wang, B. (2022). Hyperlipidemia and hypothyroidism. ClinicaChimica Acta.
Jalil, N. I., Baban, R. S., & Mahmoud, A. A. (2021). Influence of Thyroid Disorders on Liver Function Tests in–Diyala Governorate. Diyala Journal of Medicine, 21(1), 13-19
Ko, S.H.; Baeg, M.K.; Han, K.D. et al.Increased liver markers are associated with higher risk of type 2 diabetes. World J. Gastroenterol. 2015;21(24):7478–7487.
Haghpanah, S.; Esmaeilzadeh, M.; Honar, N.; et al. Relationship between serum hepcidin and ferritin levels in patients with thalassemia major and intermedia in Southern Iran. Iranian Red Crescent Medical Journal, 2015; 17(7).
Papanikolaou, G.; Tzilianos, M.; Christakis, J. I.; et al. Hepcidin in iron overload disorders. Blood, 2015; 105(10): 4103-4105.
Schoorl, M.; Schoorl, M.; van, Pelt J. and Bartels, P.C. Application of Innovative Hemocytometric Parameters and Algorithms for Improvement of Microcytic Anemia Discrimination. Hematol Rep. 2015;7(2):5843.
Valore, E.V. and Ganz T. Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin". Blood Cells Mol. Dis ,2008; 40 (1): 132–8.
Roy, C. N., Mak, H. H., Akpan, I., Losyev, G., Zurakowski, D., & Andrews, N. C. (2007). Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. Blood, 109(9), 4038-4044.
Yayar, Ö., Eser, B., & Kılıç, H. (2018). Relation between high serum hepcidin-25 level and subclinical atherosclerosis and cardiovascular mortality in hemodialysis patients. Anatolian journal of cardiology, 19(2), 117.
COOPER, D. S., HALPERN, R., WOOD, L. C., LEVIN, A. A., & Ridgway, E. C. (1984). L-thyroxine therapy in subclinical hypothyroidism: a double-blind, placebo-controlled trial. Annals of internal medicine, 101(1), 18-24.
Eghtedari, B., & Correa, R. (2020). Levothyroxine. StatPearls.
Rousset, B., Dupuy, C., Miot, F., & Dumont, F. (2015). Chapter 2. Thyroid hormone synthesis and secretion .
Wallach, H. N.& Conta, R. L. (1981). U.S. Patent No. 4,304,236. Washington, DC: U.S. Patent and Trademark Office..
Reitman, 5., and Frankel, S. Amer. J. Clin. Path. 1957: 28: 56.
Belified A,GoldbergD.M.,Revised assay for serum phenylphosphatase activity using 4-aminoantipyrine ,Enzyme,1971,12,P.561-573.
Filipowicz, D., Hernik, A., Szczepanek-Parulska, E., &Ruchała, M. (2019, May). Can hepcidin be a useful marker in the diagnosis and monitoring of de Quervainthyroiditis?. In Endocrine Abstracts (Vol. 63). Bioscientifica.
Liu, L., Yu, Y., Zhao, M., Zheng, D., Zhang, X., Guan, Q., ... & Zhang, H. (2017). Benefits of levothyroxine replacement therapy on nonalcoholic fatty liver disease in subclinical hypothyroidism patients. International journal of endocrinology, 2017.
Bruinstroop, E., Dalan, R., Cao, Y., Bee, Y. M., Chandran, K., Cho, L. W., ... & Yen, P. M. (2018). Low-dose levothyroxine reduces intrahepatic lipid content in patients with type 2 diabetes mellitus and NAFLD. The Journal of Clinical Endocrinology & Metabolism, 103(7), 2698-2706.
Ruchala, P., & Nemeth, E. (2014). The pathophysiology and pharmacology of hepcidin. Trends in pharmacological sciences, 35(3), 155-161.
Rodriguez, R., Jung, C. L., Gabayan, V., Deng, J. C., Ganz, T., Nemeth, E., & Bulut, Y. (2014). Hepcidin induction by pathogens and pathogen-derived molecules is strongly dependent on interleukin-6. Infection and immunity, 82(2), 745-752.
Bartalena, L., Brogioni, S., Grasso, L., & Martino, E. (1993). Increased serum interleukin-6 concentration in patients with subacute thyroiditis: relationship with concomitant changes in serum T4-binding globulin concentration. Journal of Endocrinological Investigation, 16(3), 213-218.
Ambiger, S., &Chincholikar, S. P. (2019). Study of Liver Function Tests in Patients of Hypothyroidism.
Yadav, A., Arora, S., Saini, V., Arora, M. K., Singh, R., & Bhattacharjee, J. (2013). Influence of thyroid hormones on biochemical parameters of liver function: a case-control study in North Indian population. Internet Journal of Medical Update-EJOURNAL, 8(1).
Duong, N., Lee, A., & Lewis, J. (2018). Case of acute mixed liver injury due to hypothyroidism. Case Reports, 2018, bcr-2017.
Al-Janabi, G., Hassan, H. N., & Al-Fahham, A. (2022). Biochemical changes in patients during hypothyroid phase after thyroidectomy. Journal of Medicine and Life, 15(1), 104.
Abd-ALHassan J. The hepatoprotective role of the aqueous extract of ginger against the harmful effects of paracetamol in rats. Univ Thi-Qar J Sci. 2015;5(3):57–63.
S. Darbar, A. Bhattacharya, S. Chattopadhyay, et al., Antihepatoprotectivepotential of livina, a polyherbal preparation on paracetamol induced hep-atotoxicity: a comparison with silymarin, Asian J. Pharm. Clin. Res. 4 (1)(2011) 72–77
Waseem, F.; Khemomal K. A. and Sajid, R. Antioxidant status in beta – thalassemia major: A Single – center study. Indian Journal of pathology and Microbiology. 2011;54 (4): 761 – 763
Neufeld EJ. Update on iron chelators in thalassemia. Hematology 2010, the American Society of Hematology Education Program Book. 2010 Dec 4;2010(1):451-5.
Colah, K.I.; Gorakshakar, A. Burden of thalassemia in India: The road map for control. PediatrHematol Oncol J 2018;2:79-84.
Abreu, I. C. M. E. D., Guerra, J. F. D. C., Pereira, R. R., Silva, M., Lima, W. G. D., Silva, M. E., & Pedrosa, M. L. (2014). Hypercholesterolemic diet induces hepatic steatosis and alterations in mRNA expression of NADPH oxidase in rat livers. ArquivosBrasileiros de Endocrinologia&Metabologia, 58, 251-259.
Origa R. Β-thalassemia. Genet Med 2017; 19:609-19.
Al-Obaidi, W. M. L., & Al-Izzi, M. H. M. (2021). Study of Hepcidin and Many Physiological and Hematological Parameters in Women with Polycystic Ovary in Kirkuk City. Annals of the Romanian Society for Cell Biology, 7494-7504.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Get vaccinated when it is your turn and follow the local guidelines. International Journal of Health Sciences, 5(3), x-xv. https://doi.org/10.53730/ijhs.v5n3.2938
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
